Visit COVID-19 resources

[Skip to Content]

Second-year visual acuity outcomes of nAMD patients treated with aflibercept: data analysis from the UK Aflibercept Users Group – (Eye Journal AOP)

16 June 2017

This news item is available to RCOphth members only, please log in below to access.

Members Login